Medidata Solutions (MDSO) 57.59 $MDSO
Best Performing Stocks On Earnings
Bespoke Investment Group - at Seeking Alpha - Sun Apr 26, 3:00AM CDT
The average stock that has reported this season has gained 0.71% on its earnings reaction day (the first trading day following its report). Below is a list of the stocks that have done the best on their earnings reaction days. As shown, Travelzoo...
TZOO: 12.89 (-0.14), ASPS: 23.24 (+0.76), SKX: 89.66 (+2.79), SXC: 17.43 (-0.09), HSTM: 31.02 (+0.88), ZEP: 19.88 (-0.03), SQNS: 2.10 (-0.15), TTS: 14.01 (-0.17), GIMO: 29.75 (+6.16), DCO: 32.10 (+1.06), PIR: 13.29 (+0.23), APOG: 53.48 (+0.55), CNMD: 53.40 (-0.83), DPZ: 113.96 (+4.73), PGI: 10.79 (+1.29), TCPI: 3.86 (-0.07), VASC: 35.31 (+0.45), AAN: 32.80 (+3.43), MSFT: 47.87 (+4.53), AMZN: 445.10 (+55.11), HAS: 71.61 (-0.10), ATI: 34.61 (+0.05), ECHO: 32.68 (-1.14), ACTG: 11.10 (+1.08), MDSO: 57.59 (+0.05), CAMP: 20.34 (-1.41), HA: 23.60 (+2.10), RMBS: 13.99 (-0.31), CLB: 124.69 (-0.63), ADPT: 63.78 (+2.13), NFLX: 558.40 (-0.66), TBI: 29.20 (+4.39), RS: 63.14 (+0.45), CE: 65.85 (+0.75), CPHD: 58.97 (+5.67), CLGX: 39.45 (+0.23), WIRE: 45.34 (+3.93), BAS: 8.70 (+0.62), FTNT: 38.68 (-0.04), EHTH: 13.50 (+2.06)
Medidata Solutions Shares Up 20.9% Since SmarTrend's Buy Recommendation (MDSO)
Comtex SmarTrend(R) - Fri Apr 24, 9:33AM CDT
SmarTrend identified an Uptrend for Medidata Solutions (NASDAQ:MDSO) on February 18th, 2015 at $47.01. In approximately 2 months, Medidata Solutions has returned 20.86% as of today's recent price of $56.81.
MDSO: 57.59 (+0.05)
Critical Alerts For Google, E-House, Dominos Pizza, Medidata Solutions and Ariad Pharmaceuticals Released By InvestorsObserver
PR Newswire - Fri Apr 24, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for GOOGL, EJ, DPZ, MDSO and ARIA.
MDSO: 57.59 (+0.05), DPZ: 113.96 (+4.73), GOOGL: 573.66 (+16.20), ARIA: 9.71 (+0.10), EJ: 6.52 (-0.23)
Downgrade Alert for Medidata Solutions (MDSO)
Comtex SmarTrend(R) - Fri Apr 24, 8:08AM CDT
Medidata Solutions (NASDAQ:MDSO) was downgraded from Buy to Hold at Topeka today. The stock closed yesterday at $57.54 on volume of 3.1 million shares, above average daily volume of 370,000. Medidata Solutions (NASDAQ:MDSO) is currently priced 8.4% above its average consensus analyst price target of $52.73. The stock should find initial support at its 50-day moving average (MA) of $47.79 and further support at its 200-day MA of $44.93.
MDSO: 57.59 (+0.05)
Why Medidata Solutions Inc. Shares Soared Higher Today
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 23, 5:20PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares in Medidata Solutions surged...
MDSO: 57.59 (+0.05)
After Yesterday's Rally of 20.73% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Apr 23, 4:30PM CDT
Medidata Solutions (NASDAQ:MDSO) traded in a range yesterday that spanned from a low of $48.47 to a high of $57.92. Yesterday, the shares gained 20.7%, which took the trading range above the 3-day high of $47.97 on volume of 3.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDSO: 57.59 (+0.05)
Medidata Solutions Q1 2015 Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Apr 23, 2:36PM CDT
MDSO: 57.59 (+0.05)
Medidata makes CFO change
Seeking Alpha - at Seeking Alpha - Thu Apr 23, 12:13PM CDT
MDSO: 57.59 (+0.05)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Apr 23, 11:45AM CDT
CERS: 4.79 (+0.20), HBP: 3.84 (-0.10), CIDM: 0.95 (-0.02), HNI: 51.98 (+0.71), MDSO: 57.59 (+0.05), HZO: 22.88 (-1.52), NKA: 2.06 (+0.06), NVGN: 6.54 (-0.01), EGT: 2.18 (-0.02), VLTC: 11.54 (+0.50), ADPT: 63.78 (+2.13), CALI: 2.28 (-0.05), XXII: 1.35 (-0.05), LOOK: 1.97 (+0.37), ARRS: 35.76 (-1.54), SIFY: 1.46 (-0.14), SCYX: 9.47 (-0.52), CLFD: 14.25 (+0.04), VGGL: 2.55 (-0.10), MOBL: 6.97 (-0.14)
Medidata up 15.1% on Q1 beat, billings strength, guidance reiteration
Seeking Alpha - at Seeking Alpha - Thu Apr 23, 10:06AM CDT
MDSO: 57.59 (+0.05)
Medidata Solutions (MDSO) Is Strong On High Volume Today
at The Street - Thu Apr 23, 9:04AM CDT
Trade-Ideas LLC identified Medidata Solutions (MDSO) as a strong on high relative volume candidate
MDSO: 57.59 (+0.05)
Medidata Solutions (MDSO) Q1 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Apr 23, 6:55AM CDT
MDSO: 57.59 (+0.05)
Medidata beats Street 1Q forecasts
Automated Insights - Thu Apr 23, 6:22AM CDT
NEW YORK (AP) _ Medidata Solutions Inc. (MDSO) on Thursday reported first-quarter net income of $157,000, after reporting a loss in the same period a year earlier.
MDSO: 57.59 (+0.05)
Medidata Solutions beats by $0.03, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Apr 23, 5:36AM CDT
MDSO: 57.59 (+0.05)
Medidata Reports Record First Quarter 2015 Revenues
Business Wire - Thu Apr 23, 5:35AM CDT
--Record subscription revenue of $78.7 million, a 23% year-over-year increase
MDSO: 57.59 (+0.05)
Medidata Announces CFO Transition; Rouven Bergmann, CFO SAP North America to Join as Chief Financial Officer; Reaffirms 2015 Guidance
Business Wire - Thu Apr 23, 5:30AM CDT
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Rouven Bergmann is joining the company as Chief Financial Officer effective Monday, May 18, 2015. Bergmann's financial and operational experience managing a multibillion-dollar software business extends the breadth and depth of Medidata's leadership team. Medidata also reaffirmed today that there is no change to its 2015 financial guidance.
MDSO: 57.59 (+0.05)
Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 4:30PM CDT
CAM: 52.81 (+0.03), BBT: 37.78 (-0.08), LAZ: 55.89 (-0.32), JAH: 52.23 (-0.97), ASPS: 23.24 (+0.76), HSY: 94.63 (-0.30), CAB: 54.19 (-3.13), CFX: 48.31 (-0.86), FAF: 37.83 (+0.76), HP: 74.42 (-0.91), KKR: 23.39 (-0.15), AEP: 57.88 (+0.98), DNKN: 54.03 (+2.52), CLFD: 14.25 (+0.04), DAN: 21.81 (+0.01), ABBV: 66.07 (+1.82), CSL: 99.55 (+0.47), CAT: 84.60 (-0.19), BHE: 24.30 (-0.16), AVT: 43.47 (-0.28), IR: 68.63 (-0.43), COR: 50.35 (+0.52), ALK: 68.30 (+1.96), COL: 97.79 (-0.16), BKU: 33.10 (-0.29), BCC: 37.41 (-0.29), MJN: 97.94 (+1.53), IQNT: 19.31 (+0.94), ERIC: 11.41 (-0.17), DGX: 75.81 (+0.60), ALXN: 180.08 (-4.50), DOW: 51.12 (+0.12), DST: 118.00 (+0.99), MDP: 53.90 (-0.78), MMM: 158.99 (-0.67), GRA: 97.07 (+0.11), FCX: 20.82 (+0.75), CLI: 18.68 (-0.03), DHR: 83.30 (-1.39), FNB: 13.12 (-0.07), LUV: 43.49 (+0.23), DPS: 78.86 (-0.09), IVC: 20.68 (+0.14), GMT: 55.80 (+0.15), JNS: 18.51 (unch), DPZ: 113.96 (+4.73), DLX: 67.37 (-0.17), CMS: 35.16 (+0.15), LTM: 71.46 (+0.02), MDSO: 57.59 (+0.05), LLY: 71.58 (-0.82), BMS: 45.56 (+0.84), EQT: 86.59 (-0.95), MHO: 23.59 (+0.38), BTU: 4.49 (-0.01), GPK: 14.74 (+0.01), BAX: 71.14 (-0.37), EQM: 88.01 (+0.87), BEAV: 61.60 (-0.64), GM: 35.59 (-0.33), HUB.B: 109.32 (-1.00), JCI: 52.48 (-0.42)
Full-Service CRO CTI Broadens Use of Medidata Technology Platform for More Efficient, Higher Quality Clinical Trials
Business Wire - Wed Apr 15, 7:30AM CDT
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that CTI Clinical Trial and Consulting Services (CTI), a therapeutically-focused, full-service contract research organization (CRO), is expanding its use of the Medidata Clinical Cloud(R) platform to improve operational efficiencies, data accessibility and decision-making processes for its clinical trials.
MDSO: 57.59 (+0.05)
Medidata Schedules First Quarter Earnings Conference Call for April 23, 2015
Business Wire - Thu Apr 09, 7:30AM CDT
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it will release its first quarter 2015 financial results before the open of the market on Thursday, April 23, 2015. Tarek Sherif, chief executive officer, and Cory Douglas, chief financial officer, will also hold a conference call at 8:00 a.m. ET for investors and analysts to discuss the Company's results and business outlook.
MDSO: 57.59 (+0.05)
Medidata Expands Partnership with Peking University to Increase Access to Cloud-Based Technology for Clinical Trials Across China
Business Wire - Mon Apr 06, 4:30PM CDT
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced the expansion of its partnership with Peking University Clinical Research Institute (PUCRI), a world-renowned academic center dedicated to enhancing the development of high-quality clinical research and health innovation in China. Leveraging the research institute's extensive clinical development network, expertise and resources, the partnership will accelerate the adoption of the Medidata Clinical Cloud(R) platform across China and, in doing so, optimize local drug development programs by bringing operational efficiencies and greater speed to clinical trials.
MDSO: 57.59 (+0.05)
Best Performing Stocks On Earnings
Bespoke Investment Group - at Seeking Alpha - Sun Apr 26, 3:00AM CDT
The average stock that has reported this season has gained 0.71% on its earnings reaction day (the first trading day following its report). Below is a list of the stocks that have done the best on their earnings reaction days. As shown, Travelzoo...
TZOO: 12.89 (-0.14), ASPS: 23.24 (+0.76), SKX: 89.66 (+2.79), SXC: 17.43 (-0.09), HSTM: 31.02 (+0.88), ZEP: 19.88 (-0.03), SQNS: 2.10 (-0.15), TTS: 14.01 (-0.17), GIMO: 29.75 (+6.16), DCO: 32.10 (+1.06), PIR: 13.29 (+0.23), APOG: 53.48 (+0.55), CNMD: 53.40 (-0.83), DPZ: 113.96 (+4.73), PGI: 10.79 (+1.29), TCPI: 3.86 (-0.07), VASC: 35.31 (+0.45), AAN: 32.80 (+3.43), MSFT: 47.87 (+4.53), AMZN: 445.10 (+55.11), HAS: 71.61 (-0.10), ATI: 34.61 (+0.05), ECHO: 32.68 (-1.14), ACTG: 11.10 (+1.08), MDSO: 57.59 (+0.05), CAMP: 20.34 (-1.41), HA: 23.60 (+2.10), RMBS: 13.99 (-0.31), CLB: 124.69 (-0.63), ADPT: 63.78 (+2.13), NFLX: 558.40 (-0.66), TBI: 29.20 (+4.39), RS: 63.14 (+0.45), CE: 65.85 (+0.75), CPHD: 58.97 (+5.67), CLGX: 39.45 (+0.23), WIRE: 45.34 (+3.93), BAS: 8.70 (+0.62), FTNT: 38.68 (-0.04), EHTH: 13.50 (+2.06)
Medidata Solutions Shares Up 20.9% Since SmarTrend's Buy Recommendation (MDSO)
Comtex SmarTrend(R) - Fri Apr 24, 9:33AM CDT
SmarTrend identified an Uptrend for Medidata Solutions (NASDAQ:MDSO) on February 18th, 2015 at $47.01. In approximately 2 months, Medidata Solutions has returned 20.86% as of today's recent price of $56.81.
MDSO: 57.59 (+0.05)
Critical Alerts For Google, E-House, Dominos Pizza, Medidata Solutions and Ariad Pharmaceuticals Released By InvestorsObserver
PR Newswire - Fri Apr 24, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for GOOGL, EJ, DPZ, MDSO and ARIA.
MDSO: 57.59 (+0.05), DPZ: 113.96 (+4.73), GOOGL: 573.66 (+16.20), ARIA: 9.71 (+0.10), EJ: 6.52 (-0.23)
Downgrade Alert for Medidata Solutions (MDSO)
Comtex SmarTrend(R) - Fri Apr 24, 8:08AM CDT
Medidata Solutions (NASDAQ:MDSO) was downgraded from Buy to Hold at Topeka today. The stock closed yesterday at $57.54 on volume of 3.1 million shares, above average daily volume of 370,000. Medidata Solutions (NASDAQ:MDSO) is currently priced 8.4% above its average consensus analyst price target of $52.73. The stock should find initial support at its 50-day moving average (MA) of $47.79 and further support at its 200-day MA of $44.93.
MDSO: 57.59 (+0.05)
Why Medidata Solutions Inc. Shares Soared Higher Today
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 23, 5:20PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares in Medidata Solutions surged...
MDSO: 57.59 (+0.05)
After Yesterday's Rally of 20.73% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Apr 23, 4:30PM CDT
Medidata Solutions (NASDAQ:MDSO) traded in a range yesterday that spanned from a low of $48.47 to a high of $57.92. Yesterday, the shares gained 20.7%, which took the trading range above the 3-day high of $47.97 on volume of 3.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDSO: 57.59 (+0.05)
Medidata Solutions Q1 2015 Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Apr 23, 2:36PM CDT
MDSO: 57.59 (+0.05)
Medidata makes CFO change
Seeking Alpha - at Seeking Alpha - Thu Apr 23, 12:13PM CDT
MDSO: 57.59 (+0.05)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Apr 23, 11:45AM CDT
CERS: 4.79 (+0.20), HBP: 3.84 (-0.10), CIDM: 0.95 (-0.02), HNI: 51.98 (+0.71), MDSO: 57.59 (+0.05), HZO: 22.88 (-1.52), NKA: 2.06 (+0.06), NVGN: 6.54 (-0.01), EGT: 2.18 (-0.02), VLTC: 11.54 (+0.50), ADPT: 63.78 (+2.13), CALI: 2.28 (-0.05), XXII: 1.35 (-0.05), LOOK: 1.97 (+0.37), ARRS: 35.76 (-1.54), SIFY: 1.46 (-0.14), SCYX: 9.47 (-0.52), CLFD: 14.25 (+0.04), VGGL: 2.55 (-0.10), MOBL: 6.97 (-0.14)
Medidata up 15.1% on Q1 beat, billings strength, guidance reiteration
Seeking Alpha - at Seeking Alpha - Thu Apr 23, 10:06AM CDT
MDSO: 57.59 (+0.05)
Medidata Solutions (MDSO) Is Strong On High Volume Today
at The Street - Thu Apr 23, 9:04AM CDT
Trade-Ideas LLC identified Medidata Solutions (MDSO) as a strong on high relative volume candidate
MDSO: 57.59 (+0.05)
Medidata Solutions (MDSO) Q1 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Apr 23, 6:55AM CDT
MDSO: 57.59 (+0.05)
Medidata beats Street 1Q forecasts
Automated Insights - Thu Apr 23, 6:22AM CDT
NEW YORK (AP) _ Medidata Solutions Inc. (MDSO) on Thursday reported first-quarter net income of $157,000, after reporting a loss in the same period a year earlier.
MDSO: 57.59 (+0.05)
Medidata Solutions beats by $0.03, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Apr 23, 5:36AM CDT
MDSO: 57.59 (+0.05)
Medidata Reports Record First Quarter 2015 Revenues
Business Wire - Thu Apr 23, 5:35AM CDT
--Record subscription revenue of $78.7 million, a 23% year-over-year increase
MDSO: 57.59 (+0.05)
Medidata Announces CFO Transition; Rouven Bergmann, CFO SAP North America to Join as Chief Financial Officer; Reaffirms 2015 Guidance
Business Wire - Thu Apr 23, 5:30AM CDT
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Rouven Bergmann is joining the company as Chief Financial Officer effective Monday, May 18, 2015. Bergmann's financial and operational experience managing a multibillion-dollar software business extends the breadth and depth of Medidata's leadership team. Medidata also reaffirmed today that there is no change to its 2015 financial guidance.
MDSO: 57.59 (+0.05)
Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 4:30PM CDT
CAM: 52.81 (+0.03), BBT: 37.78 (-0.08), LAZ: 55.89 (-0.32), JAH: 52.23 (-0.97), ASPS: 23.24 (+0.76), HSY: 94.63 (-0.30), CAB: 54.19 (-3.13), CFX: 48.31 (-0.86), FAF: 37.83 (+0.76), HP: 74.42 (-0.91), KKR: 23.39 (-0.15), AEP: 57.88 (+0.98), DNKN: 54.03 (+2.52), CLFD: 14.25 (+0.04), DAN: 21.81 (+0.01), ABBV: 66.07 (+1.82), CSL: 99.55 (+0.47), CAT: 84.60 (-0.19), BHE: 24.30 (-0.16), AVT: 43.47 (-0.28), IR: 68.63 (-0.43), COR: 50.35 (+0.52), ALK: 68.30 (+1.96), COL: 97.79 (-0.16), BKU: 33.10 (-0.29), BCC: 37.41 (-0.29), MJN: 97.94 (+1.53), IQNT: 19.31 (+0.94), ERIC: 11.41 (-0.17), DGX: 75.81 (+0.60), ALXN: 180.08 (-4.50), DOW: 51.12 (+0.12), DST: 118.00 (+0.99), MDP: 53.90 (-0.78), MMM: 158.99 (-0.67), GRA: 97.07 (+0.11), FCX: 20.82 (+0.75), CLI: 18.68 (-0.03), DHR: 83.30 (-1.39), FNB: 13.12 (-0.07), LUV: 43.49 (+0.23), DPS: 78.86 (-0.09), IVC: 20.68 (+0.14), GMT: 55.80 (+0.15), JNS: 18.51 (unch), DPZ: 113.96 (+4.73), DLX: 67.37 (-0.17), CMS: 35.16 (+0.15), LTM: 71.46 (+0.02), MDSO: 57.59 (+0.05), LLY: 71.58 (-0.82), BMS: 45.56 (+0.84), EQT: 86.59 (-0.95), MHO: 23.59 (+0.38), BTU: 4.49 (-0.01), GPK: 14.74 (+0.01), BAX: 71.14 (-0.37), EQM: 88.01 (+0.87), BEAV: 61.60 (-0.64), GM: 35.59 (-0.33), HUB.B: 109.32 (-1.00), JCI: 52.48 (-0.42)
Full-Service CRO CTI Broadens Use of Medidata Technology Platform for More Efficient, Higher Quality Clinical Trials
Business Wire - Wed Apr 15, 7:30AM CDT
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that CTI Clinical Trial and Consulting Services (CTI), a therapeutically-focused, full-service contract research organization (CRO), is expanding its use of the Medidata Clinical Cloud(R) platform to improve operational efficiencies, data accessibility and decision-making processes for its clinical trials.
MDSO: 57.59 (+0.05)
Medidata Schedules First Quarter Earnings Conference Call for April 23, 2015
Business Wire - Thu Apr 09, 7:30AM CDT
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it will release its first quarter 2015 financial results before the open of the market on Thursday, April 23, 2015. Tarek Sherif, chief executive officer, and Cory Douglas, chief financial officer, will also hold a conference call at 8:00 a.m. ET for investors and analysts to discuss the Company's results and business outlook.
MDSO: 57.59 (+0.05)
Medidata Expands Partnership with Peking University to Increase Access to Cloud-Based Technology for Clinical Trials Across China
Business Wire - Mon Apr 06, 4:30PM CDT
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced the expansion of its partnership with Peking University Clinical Research Institute (PUCRI), a world-renowned academic center dedicated to enhancing the development of high-quality clinical research and health innovation in China. Leveraging the research institute's extensive clinical development network, expertise and resources, the partnership will accelerate the adoption of the Medidata Clinical Cloud(R) platform across China and, in doing so, optimize local drug development programs by bringing operational efficiencies and greater speed to clinical trials.
MDSO: 57.59 (+0.05)
